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Abstract
Introduction. Seasonal variations in hemoglobin-A1c have been reported in diabetic patients, but the underlying mechanisms
have not been elucidated.
Aims. To study if insulin sensitivity, insulin secretion, and fasting plasma glucose showed seasonal variations in a Swedish
population-based cohort of elderly men.
Methods. Altogether 1117 men were investigated with a euglycemic insulin clamp and measurements of fasting plasma
glucose and insulin secretion after an oral glucose tolerance test. Values were analyzed in linear regression models with an
indicator variable for winter/summer season and outdoor temperature as predictors.
Results. During winter, insulin sensitivity (M/I, unit = 100  mg  min
-1  kg
-1/(mU  L
-1)) was 11.0% lower (4.84 versus
5.44, P = 0.0003), incremental area under the insulin curve was 16.4% higher (1167 versus 1003 mU/L, P = 0.007). Fasting
plasma glucose was, however, not statistically signiﬁcantly different (5.80 versus 5.71 mmol/L, P = 0.28) compared to the
summer season. There was an association between outdoor temperature and M/I (0.57 units increase (95% CI 0.29–0.82,
P < 0.0001) per 10C increase of outdoor temperature) independent of winter/summer season. Adjustment for life-
style factors, type 2 diabetes, and medication did not alter these results.
Conclusions. Insulin sensitivity showed seasonal variations with lower values during the winter and higher during the summer
season. Inverse compensatory variations of insulin secretion resulted in only minor variations of fasting plasma glucose. Insulin
sensitivity was associated with outdoor temperature. These phenomena should be further investigated in diabetic patients.
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Introduction
HbA1c has been reported to show seasonal variations
in diabetic patients (1–3). Whether corresponding
seasonal variations of insulin sensitivity occur is
largely unknown. Studies are inconclusive, with
some demonstrating higher insulin sensitivity during
the warm season (4), whereas others (5) fail to ﬁnd a
seasonal variation. Bunout et al. (6) ﬁnd decreased
insulin sensitivity during the warm season in elderly
people. These studies use repeated measures designs
but have limitations in small numbers of participants
and in using insulin sensitivity measurements by
surrogate methods based on fasting serum insulin
concentrations.
Exposure to variations of outdoor temperature
(ODT), one possible determinant of seasonal varia-
tions of insulin sensitivity, is more pronounced in
Sweden, located in the subarctic and the northern
part of the temperate climate zone, as compared to
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and in the tropical climate zones. There is a 21C
difference between the average temperatures for the
extreme months of July and February in the middle
part of Sweden (http://www.smhi.se). Basal metabolic
rates co-vary with ODT (7), and heat treatment of rats
increases skeletal muscle insulin sensitivity (8). Little is
known of the effect of low ODT on human insulin
sensitivity. A study under Swedish climatic conditions,
with measurements of insulin sensitivity covering the
whole calendar year, was a suitable strategy to inves-
tigate possible seasonal variations of insulin sensitivity.
Insulin sensitivity, insulin secretion, and their inter-
action are underlying mechanisms in type 2 diabetes
and its development (9), with a particularly high
type 2 diabetes risk for the combination of the lowest
tertiles of insulin sensitivity and insulin secretion. For
normal glucose tolerance individuals, insulin secre-
tion and insulin sensitivity are linked through a neg-
ative feedback loop, whereby pancreatic beta cells
compensate for changes in whole-body insulin sensi-
tivity through a proportionate and reciprocal change
in insulin secretion (10,11). Therefore, we sought to
investigate if insulin sensitivity oscillations over the
calendar year were mirrored by inverse insulin secre-
tion variations in a population-based setting.
The aim of this study was to examine if seasonal
variations (deﬁned as winter/summer season) of fasting
plasma glucose (FPG) and insulin-mediated glucose
uptake using the gold standard euglycemic insulin
clamp technique occurred in a population-based
cohort of 71-year-old men and if corresponding varia-
tions of insulin secretion occurred, when measured by
the incremental area under the insulin curve (AUC)
during a 2-h oral glucose tolerance test (OGTT).
Materials and methods
Ethics statement
The study was approved by the local ethics committee,
and all participants gave their informed consent. The
Uppsala Longitudinal Study of Adult Men (ULSAM)
was started in 1970 before any legislation on ethics
approval was in place in Sweden. The study was
performed in accordance with ethical guidelines at
that time, including the Helsinki Declaration (WMA
1964), and a verbal consent documented in the patient
ﬁle was considered to be a correct procedure. Later on,
participants were invited for reinvestigations and at
the third cycle (1991–1995), constituting the data
included in this publication, a written informed con-
sent was obtained as well as the approval of the local
ethics committee at the Uppsala University, Faculty of
Medicine. Further, approval of and informed consent
to link national register data has also been obtained in
writing. The full name of the ethics review board and
its address at the time of approval: Local Ethics Com-
mittee, Faculty of Medicine, Uppsala University,
Uppsala, Sweden. Today: Regionala etikprövnings-
nämnden in Uppsala, Box 1964, 751 49 Uppsala,
Sweden. The change was made due to the Act
(2003:460) concerning the Ethical Review Act. These
changes came into force in 2004, implementing the
EU-directive 2001/20 into Swedish law.
Main study
ULSAM (http://www.pubcare.uu.se/ULSAM) is a
population-based longitudinal study, still on-going
for data collection and reinvestigations at present at
age 88 years. All men born between 1920 and 1924 and
resident in the municipality of Uppsala, located in the
middle of Sweden, were invited to participate in a
health survey at age 50 years. They were examined
a tt h ea g e so f5 0( n = 2322, participation rate 81.7%),
60 (n = 1860), 71 (n = 1221), 77 (n = 839), and
82 (n = 530) years. All examinations were made at
the out-patient clinic for obesity and metabolic diseases
at Uppsala University Hospital.
The present analysis included data from men exam-
ined at age 71 years between October 1991 and May
1995.Diabeticparticipantswithinsulintreatmentwere
excluded. Plasma insulin and glucose measurements
were from a 75-g OGTT and insulin sensitivity from a
euglycemic insulin clamp investigation (n = 1117).
Reliability study
At age 71 years, a subgroup of 20 participants
was investigated twice within 4–6 weeks to determine
intra-individual variations comprising the sum of tech-
nical measurement errors and biological variations.
Anthropometric measurements
Height was measured to the nearest whole centimeter,
and body weight to the nearest 0.1 kg. The body mass
index (BMI) was calculated as the ratio of the weight
(in kilograms) to the height (in meters squared). The
waist circumference (WC) was measured midway
between the lowest rib and the iliac crest.
Data from questionnaires
A validated, optically readable, pre-coded, 7-day food
record was completed by 1050 of the 1117 men for
assessment of habitual dietary intake. Total energy
intake (kilocalories) was calculated as the mean of the
intakes over the 7 days (12).
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ical activity were ascertained through self-report by
questionnaires. High usual leisure-time physical activ-
ity (PA) was deﬁned as engagement in any active
recreational sports or heavy gardening at least 3 hours
every week or regular engagement in hard physical
training or competitive sport (13).
Biochemical measurements
From an OGTT at age 71 years, blood samples were
drawn immediately before (FPG) and 30, 60, 90, and
120 min after ingestion of 75 g anhydrous D-glucose
d i s s o l v e di n3 0 0m Lw a t e r .Plasma insulin was assa-
yed using an enzymatic immunological assay (Enzym-
mun, Boehringer Mannheim, Mannheim, Germany)
gauged in an ES300 automatic analyzer (Boehringer
Mannheim). Plasma glucose was measured by a glucose
dehydrogenase method (Gluc-DH, Merck, Darmstadt,
Germany).Theincrementalareaundertheinsulincurve
from the OGTT was calculated with the trapezoidal
rule as: Ins30 +2 Ins60+2 Ins90 +I n s 120 –6 Ins0.
Insulin resistance based on the homeostasis model
(HOMA-IR) was computed with the formula: fasting
plasma glucose (mmol/L)  fasting serum insulin
(mU/L) (14). Insulin-mediated glucose disposal was
estimated with a euglycemic insulin clamp as
described by DeFronzo (15), with insulin (Actrapid
Human, Novo, Copenhagen, Denmark) infused at a
constant rate of 56 mU/body surface area (m
2)/min
during 120 minutes. This rate was estimated to sup-
press hepatic glucose output almost completely also in
participants with type 2 diabetes. The target plasma
glucose concentration was 5.1 mmol/L. Insulin sen-
sitivity index (M/I) was calculated as glucose disposal
rate (mg glucose infused/(min  kg body weight))
divided by the mean plasma insulin concentration
(mU/L), during the last 60 min of the 120 min insulin
clamp, and multiplied by 100. The unit for M/I is
100  mg  min
-1  kg
-1/(mU  L
-1). The OGTT
and the euglycemic insulin clamp were performed
separated in time by approximately one week (16).
Total plasma 25-hydroxyvitamin D was determined
with high-performance liquid chromatography
(HPLC) atmospheric pressure chemical ionization
mass spectrometry (MS) at Vitas, Oslo, Norway using
a HP 1100 liquid chromatograph (Agilent Technol-
ogies, Palo Alto CA, USA).
Type 2 diabetes (T2DM) and impaired glucose
tolerance (IGT) were deﬁned according to the
1999 World Health Organization (WHO) criteria (16).
Measurements of temperature
The outdoor temperature (ODT) in degrees Celsius
(C) was recorded at the Swedish Air Force base (F16),
located 4 km north of Uppsala center, using calibrated
scales. Data were bought from the Swedish Meteoro-
logical and Hydrological Institute (SMHI, Norrköping,
Sweden) (http://www.smhi.se) as monthly mean values
for each month from August 1991 to May 1995. For
each participant the mean ODT of the month for the
euglycemic insulin clamp investigation and the two
preceding months was used as the ODT exposure value.
Statistical methods
All continuous variables were summarized with
number of observations and mean (standard devia-
tion) for winter (October–April) and summer (May–
September) seasons.
The reliability of M/I, HOMA-IR, AUC, FPG, 2-h
plasma glucose, height, weight, BMI, and WC were
displayed as coefﬁcients of variation (CV).
To meet the assumptions of the regression models
FPG, 2-h glucose, and BMI were transformed with a
logarithmic function, while M/I and AUC were trans-
formed with the square root function.
Values from October 1991 to May 1995 for the con-
tinuous variables M/I, HOMA-IR, AUC, FPG and 2-h
glucose, energy intake, height, weight, BMI, WC, and
vitamin D concentrations were examined for putative
seasonal effects with an indicator variable for winter/
summer season, in linear regression models. Similarly,
smoking, T2DM, IGT, and medication (oral hypogly-
cemic agents and antihypertensives) were examined for
winter/summer effects, in logistic regression models.
M/I and HOMA-IR were also examined for the effect
of ODT and the combined effect of winter/summer
s e a s o na n dO D T .A ne x t e n d e dm o d e lw a se s t i m a t e d
where the seasonal effects on M/I and HOMA-IR were
adjusted for energy intake, BMI, WC, vitamin D, smok-
ing,T2DM,IGT,andmedication.Allregressionmodels
were adjusted for age at examination. The models
were examined for autocorrelation of residuals with
the Durbin–Watson test statistic. No adjustment was
madewhentheteststatisticwasbetween1.5and2.5(17).
All statistical tests were two-tailed, and a P value
of less than 0.05 was considered a statistically signif-
icant result. The statistical packages SAS
  (v. 9.1) and
R (v. 2.8.0) were used.
Results
Crude models
Duringwinter,comparedwithsummerseason,M/Iwas
11.0%lower(4.84versus5.44units,P=0.0003),AUC
was16.4%higher(1167versus1003mU/L,P=0.007),
WC was 1.4% higher (95.0 versus 93.7 cm, P = 0.03),
whileFPG(5.80versus5.71mmol/L,P=0.28)and2-h
plasma glucose were similar (8.35 versus 8.27 mmol/L,
Seasonal variations of insulin sensitivity 37P = 0.58). There were no statistically signiﬁcant
differences between winter and summer as regards
HOMA-IR, BMI, energy intake, smoking, usual
leisure-time PA, glucose tolerance state (T2DM,
IGT, or NGT), or medication (oral hypoglycemic
agents and antihypertensives) (Table I). All Durbin–
Watsonteststatisticvalueswerebetween1.76and2.03.
Adjusted models
M/I was lower (P = 0.0006) and AUC was higher
(P = 0.024) during winter, compared with summer
season, with adjustment for age, BMI, WC, energy
intake, vitamin D, smoking, glucose tolerance state
(T2DM, IGT, or NGT), medication (oral hypogly-
cemic agents and antihypertensives), and PA.
The AUC, when adjusted for M/I, was 7.2% higher
(P = 0.30) during winter versus summer season.
Thus, variation of insulin sensitivity was compensated
for by an insulin secretion variation.
Effects of outdoor temperature
There was an association (P < 0.0001) between M/I
and ODT (Figure 1). The average increase of M/I was
0.57 units (95% CI 0.29–0.82) per 10C increase of
ODT. The effect of ODT on M/I was statistically
signiﬁcant (P = 0.049) when adjusted for winter/
summer season, while the effect of the latter did
not attain statistical signiﬁcance (P = 0.19). There
was no effect of ODT on HOMA-IR.
Discussion
We found seasonal variations of insulin sensitivity,
compensated for by inverse variations of insulin secre-
tion resulting in only small variations of FPG. Insulin
sensitivity was lower during the winter season inde-
pendent of alterations in BMI, WC, energy intake,
vitamin D, smoking, glucose tolerance state (T2DM,
IGT, or NGT), medication (oral hypoglycemic agents
and antihypertensives), and PA; however, the sea-
sonal variations of insulin sensitivity were associated
with the outdoor temperature independent of the
winter/summer season effects. Previous studies,
using surrogate measures of insulin sensitivity, pres-
ent inconclusive results regarding seasonal variations
of insulin sensitivity (4,5,18). Seasonal variation of
insulin secretion indicating compensatory elevation
Table I. Clinical characteristics of study participants presented for winter and summer seasons and coefﬁcients of variation determined by the
reliability study performed.
Variable Winter season Summer season P
b CV (%)
Temperature (C) 3.1 (4.4) 10.9 (3.2) –
M/I (100  mg  min
-1  kg
-1/(mU  L
-1)) 4.84 (2.44) 5.44 (2.53) 0.0003 13.9
HOMA-IR (pmol  mmol/L
2) 77.0 (56.0) 81.0 (72.7) 0.11 15.6
Incremental area under insulin curve (pmol  min/L) 1167 783 1003 (632) 0.007 42.6
Fasting plasma glucose (mmol/L) 5.80 (1.52) 5.71 (1.32) 0.28 5.8
2-h plasma glucose (OGTT) (mmol/L) 8.35 (4.03) 8.27 (4.09) 0.58 14.2
Energy intake (kcal)
a 1735 456 1772 (467) 0.22
Height (cm) 174.8 (5.8) 174.7 (6.4) 0.88 0.0
Weight (kg) 80.7 (11.4) 79.6 (11.9) 0.18 0.8
BMI (kg/m
2) 26.4 (3.4) 26.0 (3.4) 0.12 0.8
Waist circumference (cm) 95.0 (9.5) 93.7 (9.7) 0.03 2.3
25-Hydroxyvitamin D (nmol/L) 66.5 (17.8) 72.5 (20.7) < 0.0001
Smoker (%) 20.5 20.9 0.88
High usual leisure time physical activity (%) 60.0 63.9 0.23
Type 2 diabetes (%) 14.3 16.0 0.52
Impaired glucose tolerance (%) 13.1 12.1 0.67
Diabetes medicine: per oral (%) 5.3 3.4 0.15
Hypertension medicine: ACE inhibitors (%) 6.1 6.1 0.99
Hypertension medicine: beta blockers (%) 19.6 17.2 0.33
Data presented are: Mean (SD) or % for winter season (October–April), n = 810; and summer season (May–September), n = 307. Coefﬁcients
of variation (CV) from the reliability study, n = 20.
aData on energy intake is presented from a subset (winter season, n = 762; summer season, n = 288).
bAdjusted for age.
38 L. Berglund et al.during the winter has been observed (19) in a small
study of 50-year-old men, using the sum of insulin
determinations during an OGTT.
Diabetic patients lack the ability to increase insulin
secretion to compensate for a decrease in insulin
sensitivity (1–3), and therefore it is likely that the
reported increase of HbA1c is largely determined
by seasonal variations in insulin sensitivity. This
hypothesis should be formally tested in future studies
on diabetes patients.
HOMA-IR did not show a seasonal variability. In
our reliability study (n = 20) the coefﬁcient of variation
(CV) for M/I was 13.9%, and 15.6% for HOMA-IR,
for which a higher CV of 23.5% is reported (14).
Different reliability for M/I and HOMA-IR is a partial
explanationofthe discrepancybetweenseasonal effects
for these two measures. Further, M/I and HOMA-
IR reﬂect different aspects of insulin sensitivity: M/I
primarily skeletal muscle and hepatic to a low extent,
whereas HOMA-IR reﬂects both hepatic and skeletal
muscle insulin sensitivity. The temperature effect on
insulin sensitivity is present mainly in the peripheral
tissue skeletal muscle (20), supported by observed
increases of skeletal muscle insulin sensitivity in rats
(8) and in diabetic mice (21) by heat treatment.
Basal metabolic rates (7) co-varywith ODT.Antarc-
tic residence, exposing humans to extreme cold, is
associated with increased TSH response to TSH-
releasing hormone and decreased thyroxin (FT4),
which correlate with metabolic markers, such as total
andLDL-cholesterol,ofthyroidhormoneactivityinthe
liverandadiposetissue(22).LownormalFT4levelsare
also associated with decreased insulin sensitivity (23).
These hormonal alterations may contribute to the
greater impact of ODT than winter/summer season
on insulin sensitivity ﬂuctuations. Increase in active
vitamin D induced by sunlight exposure during the
summer is directly associated with insulin sensitivity
(24), but adjustment for vitamin D did not alter the
winter/summerdifferenceofinsulinsensitivity.Vitamin
D was determined with HPLC method, which, in a
study by Snellman et al. (25), proves to have very good
reliability. Energyintakewasmeasuredwitha validated
opticallyreadable7-dayfoodrecord(12).Dietaryintake
isdifﬁculttomeasurewithhighprecision,but,exceptfor
methods based on food weighing, our method is the
most accurate. Thus, lack of precision and resulting
residual confounding probably cannot explain that
adjustments for vitamin D and energy intake did not
remove the seasonal effects on insulin sensitivity.
Alterations in physical activity are closely related to
ODT and winter/summer seasons and also a strong
determinant of insulin sensitivity. Increased insulin
sensitivity during summer may be due to more intense
physical activity. However, the participants provided
data only on average yearly estimates of leisure time
physical activity. As gardening during summer and
snow shoveling during winter were physical activities
frequently performed by study participants, in addition
to walking, one may consider that physical activity in
this age-group of retired men would be less variable
over the calendar year than in younger people.
The strength of these results is that the ULSAM
study is large and population-based, investigated with
the euglycemic insulin clamp to assess insulin sensi-
tivity. Investigations were performed around the cal-
endar year for 4 years. The population represents a
homogeneous sample for age, gender, and ethnicity.
Weaknesses are that extrapolation to women, younger
individuals, and other ethnic groups must be made
with caution and that we lack data on TSH.
In conclusion, seasonal variations of insulin sensi-
tivity, measured with euglycemic insulin clamp, were
compensated for by inverse variations of insulin
secretion resulting in only small variations of plasma
glucose. These phenomena should be further inves-
tigated in diabetic patients.
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Figure 1. Mean values of insulin sensitivity index M/I (solid line)
(100  mg  min
-1  kg
-1/(mU  L
-1)) from a euglycemic insulin
clamp, and outdoor temperature (dotted line) (degrees Celsius),
versus winter (W) and summer (S) seasons of the year from the
years 1991 to 1995. Outdoor temperature is the mean of observed
outdoor temperatures of the month of the investigation and the
2 months preceding it.
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